HDAC inhibitors increase NRF2-signaling in tumour cells and blunt the efficacy of co-adminstered cytotoxic agents

Michael McMahon, Kathryn H. Campbell, A. Kenneth MacLeod, Lesley A. McLaughlin, Colin J. Henderson, C. Roland Wolf (Lead / Corresponding author)

    Research output: Contribution to journal › Article › peer-review

    20 Citations (Scopus)
    253 Downloads (Pure)

    Fingerprint

    Dive into the research topics of 'HDAC inhibitors increase NRF2-signaling in tumour cells and blunt the efficacy of co-adminstered cytotoxic agents'. Together they form a unique fingerprint.

    Keyphrases

    Pharmacology, Toxicology and Pharmaceutical Science